87 related articles for article (PubMed ID: 2609600)
1. [The nonspecific correction of phagocytosis in patients with foot mycoses].
Svirid SG
Vrach Delo; 1989 Nov; (11):99-100. PubMed ID: 2609600
[TBL] [Abstract][Full Text] [Related]
2. [The esterase activity of the peripheral blood in patients with foot mycoses].
Svirid SG
Vestn Dermatol Venerol; 1989; (9):56-8. PubMed ID: 2609767
[TBL] [Abstract][Full Text] [Related]
3. [Oxygen-dependent phagocytosis in patients with tinea pedis during treatment].
Svirid SG
Vestn Dermatol Venerol; 1990; (8):67-9. PubMed ID: 2256388
[TBL] [Abstract][Full Text] [Related]
4. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
[No Abstract] [Full Text] [Related]
5. [Clinico-mycologic analysis of the effectiveness of treatment in patients with rubrophytosis of the feet].
Vashchuk ZhE; Svirid SG; Marakhovskiĭ AV
Vrach Delo; 1989 Jan; (1):92-4. PubMed ID: 2718461
[TBL] [Abstract][Full Text] [Related]
6. [Esterase activity of the peripheral blood phagocytes and its nonspecific correction in patients with rubromycosis pedis].
Svirid SG; Vlasenko VV; Svirid AA
Vrach Delo; 1988 Jul; (7):92-3. PubMed ID: 3188485
[No Abstract] [Full Text] [Related]
7. [A comprehensive assessment of the phagocytic activity of the blood neutrophils in patients with rubromycosis treated with griseofulvin and nizoral].
Belukha UK; Bidrat MS; Luk'ianova AS
Vestn Dermatol Venerol; 1989; (1):50-2. PubMed ID: 2524142
[TBL] [Abstract][Full Text] [Related]
8. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
Klaschka F; Gartmann H; Weidinger G
Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
[TBL] [Abstract][Full Text] [Related]
9. [Foot mycoses and our experience in controlling them].
Belukha UK; Deboĭ LN; Fomina ZN; Kim AN
Vestn Dermatol Venerol; 1974 May; 48(4):82-5. PubMed ID: 4275721
[No Abstract] [Full Text] [Related]
10. [Nonspecific immunologic responsiveness in mycosis caused by Trichophyton mentagrophytes and ways of improving the methods of therapy].
Pavlik LV
Vestn Dermatol Venerol; 1973 Jun; 47(6):26-31. PubMed ID: 4764152
[No Abstract] [Full Text] [Related]
11. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
Romero-Cerecero O; Rojas G; Navarro V; Herrera-Arellano A; Zamilpa-Alvarez A; Tortoriello J
Planta Med; 2006 Nov; 72(14):1257-61. PubMed ID: 17051456
[TBL] [Abstract][Full Text] [Related]
12. [Naftifin in foot mycoses. Double-blind therapeutic comparison with clotrimazole].
Haas PJ; Tronnier H; Weidinger G
Mykosen; 1985 Jan; 28(1):33-40. PubMed ID: 3883160
[No Abstract] [Full Text] [Related]
13. Step-wise treatment of athlete's foot (tinea pedis) using isoconazole combined with a corticosteroid followed by isoconazole alone.
Olkhovskaya KB; Perlamutrov Y
Mycoses; 2008 Sep; 51 Suppl 4():50-1. PubMed ID: 18783571
[No Abstract] [Full Text] [Related]
14. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on Tinea pedis: a controlled and randomized clinical trial.
Herrera-Arellano A; Rodríguez-Soberanes A; de los Angeles Martínez-Rivera M; Martínez-Cruz E; Zamilpa A; Alvarez L; Tortoriello J
Planta Med; 2003 May; 69(5):390-5. PubMed ID: 12802717
[TBL] [Abstract][Full Text] [Related]
15. [Clinical trial of domestic drug polyoxidonium in secondary immunodeficiency].
Borisova AM; Laktionova LV; Setdikova NKh
Ter Arkh; 1998; 70(10):52-7. PubMed ID: 9864806
[TBL] [Abstract][Full Text] [Related]
16. [Antifungal properties of Freskin].
Rubisz-Brzezińska J; Noras A; Bendkowski W
Przegl Dermatol; 1978; 65(6):703-7. PubMed ID: 725112
[No Abstract] [Full Text] [Related]
17. What defines the quality of patient care in tinea pedis?
Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
[TBL] [Abstract][Full Text] [Related]
18. Clinical antifungal activity of thiabendazole.
Battistini F; Zaias N; Sierra R; Rebell G
Arch Dermatol; 1974 May; 109(5):695-9. PubMed ID: 4275184
[No Abstract] [Full Text] [Related]
19. [Mycosis of the feet: therapy].
Beurey J; Weber M; Mougeolle JM
Phlebologie; 1969; 22(1):83-90. PubMed ID: 5775651
[No Abstract] [Full Text] [Related]
20. Successful treatment of tinea pedis with a topical agent containing isoconazole nitrate and diflucortolone valerate.
Kye YC
Mycoses; 2008 Sep; 51 Suppl 4():48-9. PubMed ID: 18783570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
